Home › NDC Lookup › RxCUI directory › RxCUI 616366

50 ML nelarabine 5 MG/ML Injection [Arranon] — RxCUI 616366

Name: 50 ML nelarabine 5 MG/ML Injection [Arranon] (RxCUI 616366)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 616366 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI616366

Official name50 ML nelarabine 5 MG/ML Injection [Arranon]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asArranon 250 MG per 50 ML Injection; ARRANON 250 MG in 50 ML Injection

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nelarabine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Nelarabine (brand name Arranon) is a chemotherapy drug used to treat two specific types of blood cancer: T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lympho...
Nelarabine is given as an IV infusion in a clinic or hospital — you won't be taking it at home. If you're an adult, you'll receive infusions on Days 1, 3, and 5 of a 21-day cycle,...
How will I receive this medication, and how often?
The most critical thing to watch for is any change in your nervous system — things like extreme drowsiness, confusion, numbness or tingling that's getting worse, muscle weakness, d...

📖 Read our full Nelarabine Injection guide →

🕸️ Concept Web — How 50 ML nelarabine 5 MG/ML Injection [Arranon] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 50 ML nelarabine 5 MG/ML Injection [Arranon] RxCUI 616366 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Nelarabine 274771 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Arranon 613324 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Nelarabine Injection 1724135 SCDF
- Nelarabine Injectable Product 1158406 SCDG
- Nelarabine Injection [Arranon] 1724137 SBDF
- Arranon Injectable Product 1170776 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 50 ML nelarabine 5 MG/ML Injection 603566 SCD
- Nelarabine 5 MG/ML 603564 SCDC
- Nelarabine 5 MG/ML [Arranon] 616364 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

50 ML nelarabine 5 MG/ML Injection SCD · 603566
Nelarabine 5 MG/ML SCDC · 603564
Nelarabine Injection SCDF · 1724135
Nelarabine Injectable Product SCDG · 1158406

Brand-Name Concepts

Nelarabine 5 MG/ML [Arranon] SBDC · 616364
Nelarabine Injection [Arranon] SBDF · 1724137
Arranon Injectable Product SBDG · 1170776
Arranon BN · 613324

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 616366 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00078-0683-61	50 mL in 1 VIAL (0078-0683-61)	Arranon	Novartis Pharmaceuticals Corporation	2019-08-02
66758-0165-94	1 VIAL in 1 CARTON (66758-165-94) / 50 mL in 1 VIAL	Arranon	Sandoz Inc	2025-09-05

Observed labelers: Novartis Pharmaceuticals Corporation (1) · Sandoz Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J9261	Nelarabine injection	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.